We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LILY34 market cap is 151.04B. The company's latest EPS is USD 5.5202 and P/E is 151.00.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.96B | 8.31B | 9.5B | 9.35B | 8.77B |
| Operating Income | 1.49B | 2.13B | -3.24B | 2.4B | 2.51B |
| Net Income | 1.34B | 1.76B | -57.4M | 2.19B | 2.24B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.32B | 24.56B | 28.32B | 28.54B | 34.12B |
| Operating Income | 5.47B | 6.06B | 6.66B | 7.37B | 6.46B |
| Net Income | 8.32B | 6.19B | 5.58B | 6.24B | 5.24B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 53.16B | 54.81B | 57.92B | 64.01B | 63.94B |
| Total Liabilities | 41.87B | 43.66B | 46.61B | 53.14B | 51.05B |
| Total Equity | 11.29B | 11.15B | 11.31B | 10.86B | 12.9B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 39.29B | 46.63B | 48.81B | 49.49B | 64.01B |
| Total Liabilities | 36.59B | 40.81B | 39.65B | 38.71B | 53.14B |
| Total Equity | 2.7B | 5.83B | 9.15B | 10.78B | 10.86B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.73B | 2.36B | 4.55B | 4.24B | 1.17B |
| Investing | -688.8M | -1.15B | -4.23B | -7.15B | -1.18B |
| Financing | 412.3M | -621.1M | -49.1M | 3.5B | -311.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 4.84B | 6.5B | 7.26B | 7.08B | 4.24B |
| Investing | -8.08B | -2.26B | -2.76B | -3.26B | -7.15B |
| Financing | -2.32B | -3.14B | -4.13B | -5.41B | 3.5B |
| Market Cap | 151.04B |
| Price to Earnings Ratio | 151.00 |
| Price to Sales Ratio | 23.19 |
| Price to Cash Ratio | 280.75 |
| Price to Book Ratio | 72.84 |
| Dividend Yield | 0.41% |
| Shares Outstanding | 949.31M |
| Average Volume (1 week) | 20.69k |
| Average Volume (1 Month) | 23.8k |
| 52 Week Change | 119.40% |
| 52 Week High | 175.86 |
| 52 Week Low | 71.80 |
| Spread (Intraday) | 0.45 (0.28%) |
| Company Name | Lilly Drn |
| Address |
334 north senate avenue indianapolis, indiana 46204 |
| Website | https://www.lilly.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
